Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study

Background and Objectives: Limited research focuses on the risk of ischemic cerebrovascular disease associated with use of dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) in patients with type 2 diabetes mellitus in Taiwan. This study aimed to investigate the association between DPP-4 inhibitor...

Повний опис

Бібліографічні деталі

Автори:	Shih-Wei Lai, Kuan-Fu Liao, Cheng-Li Lin, Hsien-Feng Lin
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2017-11-01
Серія:	Frontiers in Pharmacology
Предмети:	diabetes mellitus DPP-4 inhibitors ischemic cerebrovascular disease National Health Insurance Program Taiwan
Онлайн доступ:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00859/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!